Thyroidprint

ThyroidPrint® is a molecular test designed to resolve the diagnostic uncertainty of indeterminate thyroid nodules (Bethesda and IV). With 96% accuracy in predicting whether a nodule is benign — and delivering results in under 3 hours — it helps avoid up to two out of three unnecessary surgeries, providing physicians and patients with a safe and reliable alternative to surgical intervention. Clinically validated through prospective multicenter trials in the United States, Chile, Spain, the United Kingdom, and Brazil, ThyroidPrint® is recognized in European and national guidelines as a trusted tool to support endocrinologists and surgeons in clinical decision-making. Now available in more than 30 countries, ThyroidPrint® is establishing itself as a precision solution in endocrinology, combining scientific innovation with direct benefits for both physicians and patients.